nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00188	0.00188	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—C3—age related macular degeneration	0.00188	0.00188	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RPE65—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RPE65—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Pramipexole—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RDH8—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—C3—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RPE65—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—C3—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Pramipexole—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ABCA4—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—SLC16A8—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ABCA4—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RHO—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—SLC16A8—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Pramipexole—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—C3—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Pramipexole—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—C3—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RHO—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—CCL2—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Pramipexole—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—C3—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—C3—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFBR1—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—CD36—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RHO—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Pramipexole—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—C3—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Pramipexole—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SQSTM1—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000989	0.000989	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—CCL2—age related macular degeneration	0.000985	0.000985	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.000977	0.000977	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000968	0.000968	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.000964	0.000964	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000963	0.000963	CbGpPWpGaD
Pramipexole—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00096	0.00096	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000953	0.000953	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000947	0.000947	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000944	0.000944	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.000929	0.000929	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000921	0.000921	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.00092	0.00092	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00091	0.00091	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.000909	0.000909	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000897	0.000897	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.000895	0.000895	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CETP—age related macular degeneration	0.000888	0.000888	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000887	0.000887	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000878	0.000878	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000864	0.000864	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CETP—age related macular degeneration	0.000863	0.000863	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000862	0.000862	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000858	0.000858	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—LIPC—age related macular degeneration	0.000857	0.000857	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000846	0.000846	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.000836	0.000836	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CETP—age related macular degeneration	0.000827	0.000827	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000825	0.000825	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000825	0.000825	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000788	0.000788	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000778	0.000778	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000767	0.000767	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.000766	0.000766	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000745	0.000745	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—C3—age related macular degeneration	0.000744	0.000744	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000734	0.000734	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.000727	0.000727	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000727	0.000727	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000719	0.000719	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000715	0.000715	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000696	0.000696	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000695	0.000695	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000694	0.000694	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000693	0.000693	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—APOE—age related macular degeneration	0.000692	0.000692	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000684	0.000684	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—KDR—age related macular degeneration	0.000678	0.000678	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000665	0.000665	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000654	0.000654	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000648	0.000648	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000647	0.000647	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000637	0.000637	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000631	0.000631	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000622	0.000622	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000609	0.000609	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000587	0.000587	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CCL2—age related macular degeneration	0.000582	0.000582	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00058	0.00058	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000578	0.000578	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.00057	0.00057	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000563	0.000563	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.00056	0.00056	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000558	0.000558	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000549	0.000549	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000545	0.000545	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CD36—age related macular degeneration	0.000533	0.000533	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.00053	0.00053	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000526	0.000526	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000524	0.000524	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000511	0.000511	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000509	0.000509	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CD36—age related macular degeneration	0.000497	0.000497	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000495	0.000495	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000488	0.000488	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000487	0.000487	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000486	0.000486	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000478	0.000478	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—APOE—age related macular degeneration	0.000471	0.000471	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000458	0.000458	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000454	0.000454	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000451	0.000451	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000446	0.000446	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000445	0.000445	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000442	0.000442	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.00044	0.00044	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APOE—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000429	0.000429	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000421	0.000421	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000411	0.000411	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.00041	0.00041	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.00041	0.00041	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000401	0.000401	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000396	0.000396	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000393	0.000393	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000387	0.000387	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000387	0.000387	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000381	0.000381	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.000375	0.000375	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—age related macular degeneration	0.000374	0.000374	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000373	0.000373	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000372	0.000372	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000367	0.000367	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000347	0.000347	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000342	0.000342	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000335	0.000335	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000334	0.000334	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000332	0.000332	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000292	0.000292	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.00028	0.00028	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000261	0.000261	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000221	0.000221	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000212	0.000212	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000184	0.000184	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000168	0.000168	CbGpPWpGaD
